Patents by Inventor Christopher C. Marvin

Christopher C. Marvin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-CD19 ANTIBODY DRUG CONJUGATES
    Publication number: 20240100181
    Abstract: The present disclosure provides anti-CD19 antibody drug conjugates (ADCs), including compositions and methods of using such ADCs.
    Type: Application
    Filed: June 15, 2023
    Publication date: March 28, 2024
    Inventors: Chewei A. Chang, Ethan D. Emberley, Adrian D. Hobson, Christopher C. Marvin, James W. Purcell
  • GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF
    Publication number: 20220354959
    Abstract: Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same, e.g., to treat autoimmune or inflammatory diseases.
    Type: Application
    Filed: May 12, 2021
    Publication date: November 10, 2022
    Applicant: AbbVie Inc.
    Inventors: Michael J. McPherson, Adrian D. Hobson, Martin E. Hayes, Christopher C. Marvin, Diana Schmidt, Wendy Waegell, Christian Goess, Jason Z. Oh, Axel Hernandez, Jr., John T. Randolph
  • ANTI-CD40 ANTIBODY DRUG CONJUGATES
    Publication number: 20220265842
    Abstract: Provided herein are anti-CD40 antibody drug conjugates comprising a radical of Formula (I), wherein R1, R2, and R3 are as defined herein. Further provided are anti-CD40 antibody drug conjugates of Formula (II), wherein Z, R, AA1, AA2, AA3, m, p, q, n, w, R1, R2, and R3 are as defined herein. Further provided are pharmaceutical compositions and kits thereof, and methods of using same.
    Type: Application
    Filed: November 29, 2018
    Publication date: August 25, 2022
    Applicant: AbbVie Inc.
    Inventors: Adrian D. Hobson, Jason Z. Oh, Michael J. McPherson, Wendy Waegell, Shaughn H. Bryant, Axel Hernandez, Jr., Claire L. Ihle, Christopher C. Marvin, Olivia A. Perng, Ling C. Santora, Lu Wang, Lu Wang
  • GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF
    Publication number: 20210015938
    Abstract: Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same.
    Type: Application
    Filed: July 31, 2020
    Publication date: January 21, 2021
    Applicant: AbbVie Inc.
    Inventors: Adrian D. Hobson, Michael J. McPherson, Wendy Waegell, Christian Goess, Axel Hernandez, Jr., Lu Wang, Lu Wang, Christopher C. Marvin, Ling C. Santora
  • GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF
    Publication number: 20200338208
    Abstract: Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same, e.g., to treat autoimmune or inflammatory diseases.
    Type: Application
    Filed: April 16, 2020
    Publication date: October 29, 2020
    Applicant: AbbVie Inc.
    Inventors: Michael J. McPherson, Adrian D. Hobson, Martin E. Hayes, Christopher C. Marvin, Diana Schmidt, Wendy Waegell, Christian Goess, Jason Z. Oh, Axel Hernandez, JR., John T. Randolph
  • Glucocorticoid receptor agonist and immunoconjugates thereof
    Patent number: 10772970
    Abstract: Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same.
    Type: Grant
    Filed: November 29, 2018
    Date of Patent: September 15, 2020
    Assignee: AbbVie Inc.
    Inventors: Adrian Hobson, Michael McPherson, Wendy Waegell, Christian Goess, Axel Hernandez, Jr., Lu Wang, Lu Wang, Christopher C. Marvin, Ling C. Santora
  • Glucocorticoid receptor agonist and immunoconjugates thereof
    Patent number: 10668167
    Abstract: Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same, e.g., to treat autoimmune or inflammatory diseases.
    Type: Grant
    Filed: May 10, 2019
    Date of Patent: June 2, 2020
    Assignee: AbbVie Inc.
    Inventors: Michael J. McPherson, Adrian D. Hobson, Martin E. Hayes, Christopher C. Marvin, Diana Schmidt, Wendy Waegell, Christian Goess, Jason Z. Oh, Axel Hernandez, Jr., John T. Randolph
  • Compositions and Methods for Treating HCV Infection
    Publication number: 20190358214
    Abstract: The present invention features compositions and methods for the treatment of HCV infection. In one embodiment, the compositions of the invention comprise (1) Compound 1 or a pharmaceutically acceptable salt thereof, and (2) Compound 2a or a pharmaceutically acceptable salt thereof. In another embodiment, the compositions of the invention comprise (1) Compound 1 or a pharmaceutically acceptable salt thereof, and (2) a prodrug of Compound 2a (e.g., one of Compounds 2b-2k or Examples 3-1 to 3-10) or a pharmaceutically acceptable salt of said prodrug.
    Type: Application
    Filed: November 13, 2017
    Publication date: November 28, 2019
    Applicant: AbbVie Inc.
    Inventors: Brian Brown, Hui-Ju Chen, David DeGoey, Geoff Halvorsen, John Hartung, Howard R. Heyman, Nathan Ide, Dale Kempf, Allen C. Krueger, Tao Li, Tongmei Li, Steven R. Martinez, Christopher C. Marvin, John T. Randolph, Eric Voight, Rolf Wagner, Jaclyn Chau
  • GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF
    Publication number: 20190262465
    Abstract: Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same, e.g., to treat autoimmune or inflammatory diseases.
    Type: Application
    Filed: May 10, 2019
    Publication date: August 29, 2019
    Applicant: AbbVie Inc.
    Inventors: Michael J. MCPHERSON, Adrian D. HOBSON, Martin E. HAYES, Christopher C. MARVIN, Diana SCHMIDT, Wendy WAEGELL, Christian GOESS, Jason Z. OH, Axel HERNANDEZ, Jr., John T. RANDOLPH
  • GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF
    Publication number: 20190167804
    Abstract: Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same.
    Type: Application
    Filed: November 29, 2018
    Publication date: June 6, 2019
    Inventors: Adrian Hobson, Michael McPherson, Wendy Waegell, Christian Goess, Axel Hernandez, JR., Lu Wang, Lu Wang, Christopher C. Marvin, Ling C. Santora
  • Anti-viral compounds
    Patent number: 10053474
    Abstract: The present invention features compounds effective in inhibiting active against Hepatitis C virus (“HCV”) polymerase. The invention also features processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
    Type: Grant
    Filed: May 5, 2017
    Date of Patent: August 21, 2018
    Assignee: AbbVie Inc.
    Inventors: Jaclyn Chau, Hui-Ju J. Chen, David A. DeGoey, John Hartung, Nathan Ide, Vikram Kalthod, Allan C. Krueger, Yi-Yin Ku, Tongmei Li, John T. Randolph, Rolf Wagner, Geoff T. Halvorsen, Christopher C. Marvin, Eric Voight, Brian S. Brown, Steven R. Martinez, Anurupa Shrestha, Howard R. Heyman
  • GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF
    Publication number: 20180126000
    Abstract: Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same, e.g., to treat autoimmune or inflammatory diseases.
    Type: Application
    Filed: June 1, 2017
    Publication date: May 10, 2018
    Applicant: AbbVie Inc.
    Inventors: Michael J. MCPHERSON, Adrian D. HOBSON, Martin E. HAYES, Christopher C. MARVIN, Diana SCHMIDT, Wendy WAEGELL, Christian GOESS, Jason Z. OH, Axel HERNANDEZ, JR., John T. RANDOLPH
  • Anti-Viral Compounds
    Publication number: 20180022763
    Abstract: The present invention features compounds effective in inhibiting active against Hepatitis C virus (“HCV”) polymerase. The invention also features processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
    Type: Application
    Filed: May 5, 2017
    Publication date: January 25, 2018
    Applicant: AbbVie Inc.
    Inventors: Jaclyn Chau, Hui-Ju J. Chen, David A. DeGoey, John Hartung, Nathan Ide, Vikram Kalthod, Allan C. Krueger, Yi-Yin Ku, Tongmei Li, John T. Randolph, Rolf Wagner, Geoff T. Halvorsen, Christopher C. Marvin, Eric Voight, Brian S. Brown, Steven R. Martinez, Anurupa Shrestha, Howard R. Heyman
  • Anti-viral compounds
    Patent number: 9676797
    Abstract: The present invention features compounds effective in inhibiting active against Hepatitis C virus (“HCV”) polymerase. The invention also features processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
    Type: Grant
    Filed: September 1, 2016
    Date of Patent: June 13, 2017
    Assignee: AbbVie Inc.
    Inventors: Hui-Ju J. Chen, David A. DeGoey, John Hartung, Nathan Ide, Vikram Kalthod, Allan C. Krueger, Yi-Yin Ku, Tongmei Li, John T. Randolph, Rolf Wagner, Jaclyn Chau, Geoff T. Halvorsen, Christopher C. Marvin, Eric Voight
  • Anti-Viral Compounds
    Publication number: 20170057981
    Abstract: The present invention features compounds effective in inhibiting active against Hepatitis C virus (“HCV”) polymerase. The invention also features processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
    Type: Application
    Filed: September 1, 2016
    Publication date: March 2, 2017
    Applicant: AbbVie Inc.
    Inventors: Hui-Ju J. Chen, David A. DeGoey, John Hartung, Nathan Ide, Vikram Kalthod, Allan C. Krueger, Yi-Yin Ku, Tongmei Li, John T. Randolph, Rolf Wagner, Jaclyn Chau, Geoff T. Halvorsen, Christopher C. Marvin, Eric Voight